PALLAS

Pallas is a biotechnology company focused on developing novel therapeutics for neurodegenerative diseases by targeting the blood-brain barrier (BBB). Founded by experts in aging and proteomics, the company leverages a proprietary platform to identify molecular drivers of BBB dysfunction and neurovascular decline. Pallas aims to restore the integrity of the BBB to protect the brain from systemic insults and slow the progression of conditions like Alzheimer's disease. Their research emphasizes the role of the vascular system in brain health and aging, representing a shift from traditional neuron-centric strategies to targeting the vascular interface of the central nervous system.